Is Henry Schein, Inc. (HSIC) Overvalued?
We dive into why Henry Schein, Inc. (HSIC) could be considered overvalued on 2026-07-23, based on AAII’s Value Score and Grade.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Commentary & Analysis
Which Is a Better Investment, CVS Health Corporation or Henry Schein, Inc. Stock?
Learn more about whether CVS Health Corporation or Henry Schein, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Jenna Brashear
Which Is a Better Investment, Centene Corporation or Henry Schein, Inc. Stock?
Learn more about whether Centene Corporation or Henry Schein, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Michael Rose
Which Is a Better Investment, Henry Schein, Inc. or UnitedHealth Group Incorporated Stock?
Learn more about whether Henry Schein, Inc. or UnitedHealth Group Incorporated is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Michael Rose
Which Is a Better Investment, HCA Healthcare, Inc. or Henry Schein, Inc. Stock?
Learn more about whether HCA Healthcare, Inc. or Henry Schein, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Rosalio Madrigal
Financial Summary
| Share Statistics | HSIC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $9,768.4 | $1,742.7 | 77% |
|
| Shares Out (Mil) | 116.1 | 76.7 | 65% |
|
| Institutional Ownership | 98.5% | 89.7% | 80% |
|
| Float (Mil) | 93.9 | 49.4 | 60% |
|
| Beta | 0.82 | 0.82 | 48% |
|
| Avg Daily Volume (000s) | 1,331 | 521 | 75% |
|
| Price Change (52-week) |
23.2% | 78.7% | 64% |
|
| Growth | HSIC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 5.4% | 11.0% | 38% |
|
| Net Income (5yr) | (0.3%) | (0.7%) | 39% |
|
| EPS (5yr) | 3.0% | 3.1% | 35 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (33.8%) | (18.0%) | 16% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 17 | 17 | 17 | |
| Current EPS | $1.239 | $5.344 | $5.906 | |
| Month Ago EPS | $1.238 | $5.348 | $5.916 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | $1.217 | $5.315 | $5.884 | |
| Year/Year Chg | 34.7% | 63.4% | 98.3% | |
| Financials | HSIC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $13,384 | $1,456 | 87% |
|
| Net Income (TTM) (Mil) | $395 | $12 | 76% |
|
| EPS (TTM) | $3.330 | $0.300 | 80% |
|
| Operating Cash Flow (TTM) (Mil) | $578 | $138 | 74% |
|
| Net Cash Flow (TTM) (Mil) | $11 | $8 | 58% |
|
| Long-Term Debt (Q1) (Mil) | $2,590 | $316 | 78% |
|
| Enterprise Value (Q1) (Mil) | $13,585 | $2,170 | 78% |
|
| Valuation | HSIC | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.00 | 2.85 | 65% |
|
| P/E | 26.0 | 26.7 | 63% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 8.4 | 1.1 | 92% |
|
| Ratios | HSIC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 31.2% | 27.8% | 37% |
|
| Net Margin | 3.0% | 1.1% | 42% |
|
| ROA | 3.6% | 1.8% | 65% |
|
| ROE | 12.0% | 7.1% | 64% |
|
| Liabilities to Assets | 57.3% | 59.9% | 50% |
|
| F-Score | 6 | 5 | 69% |
|
Henry Schein, Inc. did not pass any screens on 7/31/2026.
